Amid this epidemic, a transformative class of medications GLP-1 receptor agonists (GLP- 1RAs) has revolutionized weight loss and chronic disease management
Data was retrieved for studies from inception up to 19 April 2022
Once there, smoke-expanded pools of alveolar macrophages are paradoxically less effective: phagocytosis, autophagy, antigen presentation, and production of key cytokines such as tumor necrosis factor- (TNF-), interleukin-12 (IL-12), and interferon- (IFN-) are all attenuated, while a shift toward anti-inflammatory M2 phenotypes and smoke-induced metabolic exhaustion enable intracellular survival of the pathogen (Leemans et al., 2005
Wu T, Zhang Y, Shi Y, et al
Factors that negatively affected growth in the historic period were high discontinuation rates due to GI side effects and rising competition from alternative therapies